Skip to content

Frontlight ResearchEarly access

Institution

Sriwijaya University

Palembang, IndonesiaWebsite

Also known as: Universitas Sriwijaya

1running trial
2closed trials
32,854publications (OpenAlex)

Running trials

Recruiting
Effect of Proliverenol on Liver Fat and Insulin Resistance in Type 2 Diabetes
NCT07928661· Phase 2· Universitas Sriwijaya· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Type 2 diabetes1 recruiting

Closed trials

Completed
Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 Diabetes
NCT07569744· Universitas Sriwijaya· Source
Completed
Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang
NCT06912035· Phase 2/3· Universitas Sriwijaya· Source

Registry name variants (2)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

Universitas Sriwijaya
Palembang, South Sumatera 30126
2 trials
- NCT07569744Resveratrol for Endothelial Dysfunction and Metabolic Control in Type 2 Diabetes
- NCT06912035Efficacy of Diacerein Supplementation on Interleukin-1β, Hs-CRP, TNF-α Levels and Glycemic Control in Uncontrolled Type 2 Diabetes Mellitus Patients at Dr. Mohammad Hoesin General Hospital Palembang
University of Sriwijaya Palembang
Palembang, South Sumatera 30128
1 trial
- NCT07928661Effect of Proliverenol on Liver Fat and Insulin Resistance in Type 2 Diabetes
  Contact: Dian Wijayanti, dr. Dian Wijayanti, SpPD

Conditions

Diseases this institution publishes on or runs trials for.

Institution data: ROR 030bmb197 (CC0-1.0)Updated 14 Nov 2026

Report an error

Sriwijaya University: trials and research groups – Frontlight Research